| 2018 ESC/EACTS Guidelines on myocardial revascularization |
73 |
| Percutaneous coronary intervention for the left main stem and other bifurcation lesions: 12th consensus document from the European Bifurcation Club |
42 |
| Left atrial appendage occlusion with the AMPLATZER Amulet device: one-year follow-up from the prospective global Amulet observational registry |
39 |
| Percutaneous recanalisation of chronic total occlusions: 2019 consensus document from the EuroCTO Club |
31 |
| Validation of a novel non-hyperaemic index of coronary artery stenosis severity: the Resting Full-cycle Ratio (VALIDATE RFR) study |
31 |
| Percutaneous coronary intervention for obstructive bifurcation lesions: the 14th consensus document from the European Bifurcation Club |
25 |
| A new optical coherence tomography-based calcium scoring system to predict stent underexpansion |
24 |
| Final results of the randomised evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with a new-generation stent (REDUCE trial) |
23 |
| Real-world experience using the ACURATE neo prosthesis: 30-day outcomes of 000 patients enrolled in the SAVI TF registry |
21 |
| European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism |
20 |
| One-year outcomes of patients with severe aortic stenosis and an STS PROM of less than three percent in the SURTAVI trial |
20 |
| Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: two-year follow-up of the SYNTAX II study |
18 |
| Beyond the five-year horizon: long-term outcome of high-risk and inoperable patients undergoing TAVR with first-generation devices |
18 |
| Percutaneous coronary intervention in left main coronary artery disease: the 13th consensus document from the European Bifurcation Club |
17 |
| Prosthetic valve endocarditis after transcatheter or surgical aortic valve replacement with a bioprosthesis: results from the FinnValve Registry |
16 |
| Propensity-matched comparison of vascular closure devices after transcatheter aortic valve replacement using MANTA versus ProGlide |
16 |
| Real-world experience of the left distal transradial approach for coronary angiography and percutaneous coronary intervention: a prospective observational study (LeDRA) |
16 |
| Long-term durability and haemodynamic performance of self-expanding transcatheter heart valve beyond five years after implantation: a prospective observational study applying the standardised definitions of structural deterioration and valve failure |
15 |
| Optimising patient discharge management after transfemoral transcatheter aortic valve implantation: the multicentre European FAST-TAVI trial |
15 |
| Pacemaker dependency after transcatheter aortic valve implantation: incidence, predictors and long-term outcomes |
15 |
| Intravascular lithotripsy for calcific coronary and peripheral artery stenoses |
14 |
| Diagnostic accuracy of intracoronary optical coherence tomography-derived fractional flow reserve for assessment of coronary stenosis severity |
14 |
| Intravascular ultrasound in the evaluation and treatment of left main coronary artery disease: a consensus statement from the European Bifurcation Club |
14 |
| Complete two-year follow-up with formal non-inferiority testing on primary outcomes of the AIDA trial comparing the Absorb bioresorbable scaffold with the XIENCE drug-eluting metallic stent in routine PCI |
13 |
| Coronary artery perforation during chronic total occlusion percutaneous coronary intervention: epidemiology, mechanisms, management, and outcomes |
13 |
| Urgent balloon aortic valvuloplasty in patients with cardiogenic shock related to severe aortic stenosis: time matters |
12 |
| National trends, predictors of use, and in-hospital outcomes in mechanical circulatory support for cardiogenic shock |
12 |
| Prevalence of extra-appendage thrombosis in non-valvular atrial fibrillation and atrial flutter in patients undergoing cardioversion: a large transoesophageal echo study |
12 |
| Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population |
12 |
| Assessment of structural valve deterioration of transcatheter aortic bioprosthetic balloon-expandable valves using the new European consensus definition |
12 |
| Coronary Sinus Reducer implantation improves symptoms, ischaemia and physical capacity in patients with refractory angina unsuitable for myocardial revascularisation: a single-centre experience |
12 |
| Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting: the GRAFFITI trial |
11 |
| Benefit of a new provisional stenting strategy, the re-proximal optimisation technique: the rePOT clinical study |
11 |
| Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions |
11 |
| Physiologic evaluation of coronary lesions using instantaneous wave-free ratio (iFR) in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation |
11 |
| Two-year clinical outcome of all-comers treated with three highly dissimilar contemporary coronary drug-eluting stents in the randomised BIO-RESORT trial |
11 |
| Prevalence, predictors, and health status implications of periprocedural complications during coronary chronic total occlusion angioplasty |
11 |
| Procedural and one-year outcomes of patients treated with orbital and rotational atherectomy with mechanistic insights from optical coherence tomography |
10 |
| Medium-term results of percutaneous pulmonary valve implantation using the Venus P-valve: international experience |
10 |
| Bench testing and coronary artery bifurcations: a consensus document from the European Bifurcation Club |
10 |
| Real-world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy: results of the DAPT subgroup from the EWOLUTION all-comers study |
10 |
| Bioprosthetic aortic valve leaflet thrombosis detected by multidetector computed tomography is associated with adverse cerebrovascular events: a meta-analysis of observational studies |
10 |
| Three-year clinical and two-year multimodality imaging outcomes of a thin-strut sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 trial |
10 |
| Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary |
10 |
| Percutaneous left atrial appendage occlusion in patients with atrial fibrillation and left appendage thrombus: feasibility, safety and clinical efficacy |
10 |
| BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12 months |
10 |
| Influence of target vessel on prognostic relevance of fractional flow reserve after coronary stenting |
9 |
| Impella CP or VA-ECMO in profound cardiogenic shock: left ventricular unloading and organ perfusion in a large animal model |
9 |
| Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices |
9 |
| Comparison of acute thrombogenicity for magnesium versus stainless steel stents in a porcine arteriovenous shunt model |
9 |
